Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841919 · ClinicalTrials.gov registry record · Phase 4
Insulin Therapy in the Hospital Comparing Two Protocols
A Phase 4 study, sponsored by Cook County Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00841919 is a Phase 4 study that has completed, run by Cook County Health. The registered enrollment target is 60 participants.
The verdict
NCT00841919, a Phase 4 study, has completed, sponsored by Cook County Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if by using insulin analog (Glargine and lispro insulin) with an insulin pen the investigators are able to obtain a higher rate of correct timing of insulin and food administration as when compared to the usual therapy (insulin NPH and regular) with syringes.
Interventions
- DRUG Glargine insulin
- DRUG NPH insulin and regular insulin
- DRUG lispro insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-12 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00841919
The ClinicalTrials.gov registry entry for NCT00841919 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook County Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Glargine insulin is the first listed.
NCT00841919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00841919 about?
NCT00841919 is a clinical study titled "Insulin Therapy in the Hospital Comparing Two Protocols". The purpose of this study is to determine if by using insulin analog (Glargine and lispro insulin) with an insulin pen the investigators are able to obtain a higher rate of correct timing of insulin and food administration as when compared to the usual therapy (insulin NPH and regular) with syringes...
What is the current status of trial NCT00841919?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2006-12. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00841919?
The interventions under investigation include: Glargine insulin (DRUG), NPH insulin and regular insulin (DRUG), lispro insulin (DRUG).
Who is sponsoring clinical trial NCT00841919?
This trial is sponsored by Cook County Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.